Bluefield Hematology/Oncology Associates, INC
Bluefield Hematology/Oncology Associates, INC was paid $347K by Medicaid between Jan 2018 and Aug 2022, across 13 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 82% of everything it billed.
33Billing provider infoBLUEFIELD HEMATOLOGY/ONCOLOGY ASSOCIATES, INC
BLUEFIELD, WV 24701
BLUEFIELD, WV 24701
33aNPI1477665610assigned 08/31/2006
33bProvider typeSpecialist
28Total paid$347K
24GClaims8,952
24DCodes billed13
24AFirst – last monthJan 2018 – Aug 2022
Compared with peers
Next to other Specialist providers in West Virginia
Rank by total paid#31 of 71
Median peer was paid$232K
This provider vs. median1.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,837 | $74K | |
| 2019 | 1,750 | $64K | |
| 2020 | 2,392 | $81K | |
| 2021 | 2,029 | $81K | |
| 2022 | 944 | $46K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 82% | 7,117 | 5,502 | $286K |
| 99205 | Prolong outpt/office vis | 9.5% | 340 | 313 | $33K |
| J7050 | Infusion, normal saline solution, 250 cc | 3.9% | 940 | 474 | $13K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.6% | 212 | 174 | $5K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1.0% | 75 | 38 | $4K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 48 | 25 | $3K |
| 99070 | <1% | 45 | 38 | $1K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 48 | 39 | $496.54 |
| 96367 | <1% | 24 | 12 | $226.32 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 25 | 12 | $102.09 |
| 96523 | <1% | 28 | 24 | $43.39 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 26 | 12 | $16.98 |
1 more codes
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 24 | $3.62 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHOR, JOEL (PRESIDENT)